(Q43137579)

14 November 2017

In vivo bioassay to detect irinotecan-stabilized DNA/topoisomerase I complexes in rats (English)

1 reference

14 November 2017

5

1 reference

14 November 2017

3

Bernhard Watzl

0 references

Karlis Briviba

object named as

Karlis Briviba

2

0 references

author name string

Stephan W Barth

1

1 reference

PubMed ID

20213647

14 November 2017

Nicole Jäger

4

1 reference

PubMed ID

20213647

14 November 2017

Melanie Esselen

6

1 reference

14 November 2017

1 March 2010

1 reference

14 November 2017

Biotechnology Journal

1 reference

14 November 2017

5

1 reference

14 November 2017

3

1 reference

14 November 2017

321-327

1 reference

Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan

14 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Topoisomerase I inhibitors: camptothecins and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Topoisomerase I and II activity in human breast, cervix, lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

DNA topoisomerases: structure, function, and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Bioflavonoids as poisons of human topoisomerase II alpha and II beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Transcription-dependent degradation of topoisomerase I-DNA covalent complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Gefitinib increases serum concentrations of oral irinotecan and SN-38 without increasing the biliary concentration of SN-38 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.200900174

21 January 2018

Identifiers

DOI

10.1002/BIOT.200900174

1 reference

14 November 2017

1 reference

PubMed ID

20213647